Dbv Technologies Adr (DBVT)

Apr 13, 2026

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - GlobeNewswire Inc.

Apr 13, 2026

Apr 11, 2026

Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT) - The Globe and Mail

Apr 11, 2026

Apr 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 07, 2026

Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Forum & Discussion - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Major Holders - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Friday - Defense World

Apr 03, 2026

Apr 02, 2026

DBV technologies S.A. (ADR) (DBV1.SG) company profile and facts - Yahoo Finance UK

Apr 02, 2026

Mar 29, 2026

Guggenheim Reiterates “Buy” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World

Mar 29, 2026

Mar 27, 2026

Alphabet To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Mar 27, 2026

Mar 27, 2026

DBV Technologies Reports Full Year 2025 Financial Results and Business Update - The Manila Times

Mar 27, 2026

Mar 26, 2026

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - The Manila Times

Mar 26, 2026

Mar 26, 2026

DBV Technologies (NASDAQ: DBVT) deepens 2025 loss but funds runway into 2027 - Stock Titan

Mar 26, 2026

Mar 26, 2026

DBV files annual report in the US and France, including buyback plan - Stock Titan

Mar 26, 2026

Mar 25, 2026

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm

Mar 25, 2026

Mar 25, 2026

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - The Manila Times

Mar 25, 2026

Mar 09, 2026

DLD Asset Management LP Makes New $250,000 Investment in DBV Technologies S.A. $DBVT - Defense World

Mar 09, 2026

Mar 07, 2026

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH) - The Globe and Mail

Mar 07, 2026

Mar 05, 2026

DBV Technologies to Participate in Upcoming March Investor Conferences - The Manila Times

Mar 05, 2026

Mar 04, 2026

Biotech DBV Technologies lines up back-to-back March investor events - Stock Titan

Mar 04, 2026

Mar 03, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill

Mar 03, 2026

Mar 03, 2026

Guggenheim Sticks to Their Buy Rating for DBV Technologies SA – American (DBVT) - The Globe and Mail

Mar 03, 2026

Mar 02, 2026

DBV Technologies stock surges on new peanut patch trial data - Investing.com

Mar 02, 2026

Mar 02, 2026

Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan

Mar 02, 2026

Mar 01, 2026

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times

Mar 01, 2026

Feb 28, 2026

DBV Technologies Highlights Additional Data from Successful - GlobeNewswire

Feb 28, 2026

Feb 26, 2026

DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026

Feb 25, 2026

European ADRs Were Flat As Biotech Names Took The Lead - Finimize

Feb 25, 2026

Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail

Feb 25, 2026

Feb 24, 2026

DBV Technologies launches $150M ATM offering - MSN

Feb 24, 2026

Feb 17, 2026

BioImpact LLC reports 9.99% DBV Technologies (DBVT) stake via shares and warrants - Stock Titan

Feb 17, 2026

Feb 16, 2026

European Equities Traded in the US as American Depositary Receipts Lower Wednesday - MSN

Feb 16, 2026

Feb 16, 2026

DBV Technologies to Participate in Biotech Summit - Intellectia AI

Feb 16, 2026

Feb 16, 2026

DBV Technologies to Present VIASKIN® Data at AAAAI 2026 - Intellectia AI

Feb 16, 2026

Feb 10, 2026

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting - The Manila Times

Feb 10, 2026

Feb 10, 2026

DBV Technologies S.A. - Via Ritzau

Feb 10, 2026

Feb 09, 2026

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit - markets.businessinsider.com

Feb 09, 2026

Feb 09, 2026

Biotech summit to feature DBV Technologies CEO fireside chat - Stock Titan

Feb 09, 2026

Feb 08, 2026

DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen - Defense World

Feb 08, 2026

Feb 07, 2026

DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 07, 2026

Feb 04, 2026

European ADRs Slip As Winners And Losers Split By Region - Finimize

Feb 04, 2026

Feb 04, 2026

European ADRs Inched Higher As GSK And Telefonica Jumped - Finimize

Feb 04, 2026